Jikei-comparison of Lantus and Levemir with CGM for thinking insulin optimization

Jikei-comparison of Lantus and Levemir with CGM for thinking insulin optimization - J-Collection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001402

Enrollment

Registered

2008-09-30

Start date

2008-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

Detemir Glargine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 1 diabetes receiving Basal-bolus insulin therapy.

Exclusion criteria

Exclusion criteria: Type 2 diabetes.

Design outcomes

Primary

Measure	Time frame
Continuous glucose value of 24 hours by CGM	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026